China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drug
(Reuters) – Eli Lilly (NYSE:LLY) and Hong Kong-listed Laekna will collaborate to develop an experimental obesity drug that aims to help patients
(Reuters) – Eli Lilly (NYSE:LLY) and Hong Kong-listed Laekna will collaborate to develop an experimental obesity drug that aims to help patients
By Gram Slattery and Alexandra Ulmer (Reuters) – President-elect Donald Trump is planning to tap conservative loyalist Russell Vought to be the director
(Reuters) -Elon Musk and Vivek Ramaswamy said the government efficiency panel that President-elect Donald Trump has named them to lead will follow
By Lisandra Paraguassu BRASILIA (Reuters) – China Development Bank signed a deal on Wednesday to loan 5 billion yuan ($690 million) to Brazil’s
SEATTLE – Boeing (NYSE:BA) issued lay off notices to 692 workers in Missouri, home to the company’s Defense, Space & Security division,
By Roushni Nair (Reuters) -Australia’s HMC Capital on Thursday unveiled plans to launch DigiCo REIT, a new digital infrastructure real estate trust focused
Investing.com – Nvidia reported fiscal third-quarter results that topped Wall Street estimates, but its current-quarter guidance underwhelmed lofty investor expectations amid red-hot AI
By Jonathan Stempel (Reuters) – U.S. prosecutors unveiled criminal charges on Wednesday against five alleged members of Scattered Spider, a cybercrime group suspected
(Reuters) -Data cloud and analytics provider Snowflake (NYSE:SNOW) on Wednesday raised its annual product revenue forecast and announced a multi-year partnership with
By Luc Cohen and Jonathan Stempel NEW YORK (Reuters) -Former billionaire investor Sung Kook “Bill” Hwang was sentenced to 18 years in prison